MedPath

Teoxane SA

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:1
Completed:9

Trial Phases

2 Phases

Phase 4:2
Not Applicable:11

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Not Applicable
11 (84.6%)
Phase 4
2 (15.4%)

TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults

Not Applicable
Recruiting
Conditions
Infraorbital Hollows
First Posted Date
2024-12-27
Last Posted Date
2025-01-28
Lead Sponsor
Teoxane SA
Target Recruit Count
260
Registration Number
NCT06749587
Locations
🇨🇳

Guangdong Second Provincial General Hospital, Guangzhou, China

RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)

Not Applicable
Active, not recruiting
Conditions
Aging
Pain
First Posted Date
2024-04-22
Last Posted Date
2025-04-11
Lead Sponsor
Teoxane SA
Target Recruit Count
20
Registration Number
NCT06378086
Locations
🇺🇸

United States, Birmingham, Alabama, United States

🇵🇷

Puerto Rico, San Juan, Puerto Rico

🇺🇸

United States, New York, New York, New York, United States

TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults

Not Applicable
Recruiting
Conditions
Nasolabial Folds
First Posted Date
2024-04-16
Last Posted Date
2024-04-16
Lead Sponsor
Teoxane SA
Target Recruit Count
390
Registration Number
NCT06367634
Locations
🇨🇳

Guangdong Second Provincial General Hospital, Guangzhou, China

Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face

Not Applicable
Recruiting
Conditions
Chin Retrusion
Aging
First Posted Date
2023-08-14
Last Posted Date
2025-04-03
Lead Sponsor
Teoxane SA
Target Recruit Count
155
Registration Number
NCT05986630
Locations
🇨🇭

Care- Geneva, Geneva, Switzerland

TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines

Not Applicable
Conditions
Fine Lines of the Face and Neck
Skin Aging
First Posted Date
2022-04-27
Last Posted Date
2022-05-04
Lead Sponsor
Teoxane SA
Target Recruit Count
67
Registration Number
NCT05349799
Locations
🇪🇸

Site 4, Alicante, Spain

🇪🇸

Site 3, Barcelona, Spain

🇪🇸

Site 1, Bilbao, Spain

and more 1 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath